Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 517.0 | 69 | |
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 70.5 | 68 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIP-1B | 130.5 | 74 | |
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 1793.0 | 67 | |
RA1931 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 67.0 | 72 | ||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 69.5 | 76 | ||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 68.5 | 70 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIP-1B | 173.0 | 77 | |
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 542.0 | 68 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 103.5 | 54 | |
RA1869 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 61.0 | 67 | ||||
N2759 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 62.5 | 66 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 60.0 | 57 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 75.0 | 64 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 53.0 | 68 | ||||
N2759 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 68.0 | 73 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MIP-1B | 71.0 | 89 | ||||
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIP-1B | 123.0 | 53 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MIP-1B | 137.0 | 63 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 126.5 | 62 | |
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 517.0 | 55 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1B | 203.0 | 60 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 147.0 | 59 | |
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 86.5 | 72 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1B | 134.0 | 79 |